speb/financial-data huggingface dataset:
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.39
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 16979000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 16979000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 5294000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Assets: 4743589000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4743589000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 2769241000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2769241000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2627831000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2627831000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1372831000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1372831000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Total Expenses: 3409999000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 750670000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3370758000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3370758000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3212321000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3212321000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1691255000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1691255000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 67150000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 12649000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 12649000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Work In Process: 278650000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 278650000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Working Capital: -148235000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -148235000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 309529000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 923637000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7541135.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.41
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 543485000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 36932000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 36932000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7541135.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.41
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — EBIT: 74528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — EBITDA: 111460000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 380152000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 64977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 64977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -64977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -64977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 111460000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 10633000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Operating Income: 70623000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 923637000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3905000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 106767000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 9551000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 543485000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 36932000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -1082000.00
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
RELCHEMQ.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 853014000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 327310000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 995244000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 372583000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 222096000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 94639000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7547032.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 2.19
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11973000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1494000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 218729000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1397935000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 8088000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 602118000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1625585000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 7769000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1138079000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1145848000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1733174000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 16475000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 36977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 36977000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7547032.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.19
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — EBIT: 69411000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — EBITDA: 106388000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4360000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3043229000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 393126000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 58758000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 58758000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 723754000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3906118000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 19039000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 94639000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 4204000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1370104000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1374308000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 11050000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2506689000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -58758000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -58758000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3043229000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1393575000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 269523000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 106388000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 16528000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Operating Income: 65816000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 995244000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 443181000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1417000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1322338000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4360000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 3595000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 117976000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3035141000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 217235000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Payables: 372583000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 10653000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 602118000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 36977000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1397935000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1393575000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -5875000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 17825000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 4786852000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2768039000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2520156000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1397935000.00
RELCHEMQ.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 929428000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3388917000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3161267000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1655743000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -107589000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 297158000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 819411000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7542453.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.06
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 452257000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 36989000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 36989000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7542453.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.06
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — EBIT: 74019000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — EBITDA: 111008000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 367154000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 63203000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 63203000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -63203000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -63203000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 111008000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 7995000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Operating Income: 69996000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 819411000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 4023000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 96367000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 10816000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 452257000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 36989000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 2821000.00
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
RELCHEMQ.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 749415000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1741730000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 466494000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — +Total Revenue: 3620058000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 881766000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 242127000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 242127000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 96050000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 96050000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 307317000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 307317000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 7558009.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.31
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 5799000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -7781000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 7180000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7180000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 4051000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4051000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 300826000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 300826000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -3772000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -303332000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -256835000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 308925000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Payable: -33557000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 79453000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -202459000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1748000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 1427485000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1427485000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1619169000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 362548000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1824751000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1824751000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 4019000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4019000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1204300000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1204300000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1208319000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1208319000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1702525000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1702525000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 12867000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 12867000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Depreciation: 147924000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 147924000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 147924000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 37026000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 147924000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 37026000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 7558009.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.31
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — EBIT: 297453000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — EBIT: 79495000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — EBITDA: 445377000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — EBITDA: 116521000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — End Cash Position: 4051000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -199735000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 208691000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 9660000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 3704000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 3704000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2964952000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2964952000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Gross Profit: 2000889000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 519218000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Interest Expense: 249048000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 62110000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 249048000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 62110000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -242124000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 5480000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Inventory: 994856000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 994856000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 4096225000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4096225000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -18485000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 18854000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 18854000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 307317000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 307317000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 68030000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 3161000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3161000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1464440000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1464440000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1467601000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1467601000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 68030000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 11545000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 11545000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2664689000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2664689000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 17459000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 48405000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 17459000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Interest Income: -249048000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -62110000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -16184000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 57327000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 68030000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -249048000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -62110000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2964952000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2964952000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -7781000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -10703000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1423781000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1423781000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 266762000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 266762000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 445377000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 116521000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Normalized Income: 52615000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 17459000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 216472000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Operating Income: 259159000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Operating Income: 52724000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3620058000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 881766000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 417197000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 417197000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 85014000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 85014000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 1351888000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1351888000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 3704000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3704000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 214809000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 242630000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 242630000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 38294000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 26771000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 916349000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 254000000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2964952000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2964952000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 296775000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 296775000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Payables: 242127000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Payables: 242127000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Pretax Income: 48405000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 17385000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -16184000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -7781000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1619169000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 362548000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 147924000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 37026000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -10703000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -10703000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1427485000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1427485000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1423781000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1423781000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Tax Provision: -4210000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -74000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 15822000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 15822000.00
RELCHEMQ.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -2740000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5119578000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5119578000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2891925000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2891925000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2675920000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2675920000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1427485000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1427485000.00
RELCHEMQ.NS income_statement (annual, 2026-03-31) — Total Expenses: 3360899000.00
RELCHEMQ.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 829042000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 3692093000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3692093000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3294827000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3294827000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1989568000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1989568000.00
RELCHEMQ.NS balance_sheet (annual, 2026-03-31) — Working Capital: 122226000.00
RELCHEMQ.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 122226000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — +Operating Expense: 350035000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — +Total Revenue: 533913000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 68531000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 259390000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 102432000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 9587052.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Basic EPS: 3.63
RELIABLE.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 11034000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -73752000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Capital Expenditure Reported: -52159000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 103200000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 7644000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 9260000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -187000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 7644000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Inventory: 255000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 44802000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: -19958000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Payable: -38700000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Receivables: 16944000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 7545000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -3391000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Common Stock: 103200000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 377764000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 229205000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 111684000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Current Assets: 378285000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Current Debt: 91166000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 91166000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 19998000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 236266000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Depreciation: 3642000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 3642000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 3641000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 3641000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 9587052.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Diluted EPS: 3.63
RELIABLE.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 34801000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 10000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — EBIT: 72560000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — EBITDA: 76202000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — End Cash Position: 7643000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -979000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -9039000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 9552000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 324203000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Gross Profit: 422229000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Interest Expense: 19779000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 19779000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Interest Income: 755000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 755000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -19779000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 755000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Inventory: 252000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 519456000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -67125000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 0.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 2883000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 24994000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 50526000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 50526000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -11729000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 27877000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 37094000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Minority Interests: -2657000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 2543000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Net Debt: 134048000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income: 34801000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 34801000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 37457000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 34801000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 34801000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 53781000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 37457000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Interest Income: -19267000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 6785000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 18976000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -11729000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -19267000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 11000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -3456000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Net PPE: 324203000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -73752000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 30705000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 377764000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 3733000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 13265000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 76992000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Normalized Income: 35361637.92
RELIABLE.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 64713000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Operating Income: 72194000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Operating Revenue: 533913000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 10320000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 2581000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Investments: 8184000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 19024000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 6303000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 5767000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 344000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 325567000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Payable: 11930000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Properties: 94998000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 1616000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Other Special Charges: 1000000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Payables: 114670000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10432000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 106802000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Pretax Income: 52781000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -52159000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 111684000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 3642000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 10735000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 10735000.00
RELIABLE.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -11729000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 168141000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 540000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 10092000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Share Issued: 10320000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Special Income Charges: -1000000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 377764000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 377764000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -229362.08
RELIABLE.NS income_statement (annual, 2022-03-31) — Tax Provision: 15324000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.29
RELIABLE.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -19280000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Assets: 758145000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 428290000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Debt: 141692000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 414858000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Total Expenses: 461719000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 343287000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 379832000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 107021000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 243000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 34199000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -790000.00
RELIABLE.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -790000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 46995000.00
RELIABLE.NS balance_sheet (annual, 2022-03-31) — Working Capital: 142019000.00
RELIABLE.NS income_statement (annual, 2023-03-31) — +Operating Expense: 546343000.00
RELIABLE.NS income_statement (annual, 2023-03-31) — +Total Revenue: 728266000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 170190000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 343657000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 180774000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1522000.00
RELIABLE.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 8602597.00
RELIABLE.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.62
RELIABLE.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7643000.00
RELIABLE.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -120011000.00
RELIABLE.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -6469000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 103200000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 12679000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 14804000.00
RELIABLE.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -516000.00
RELIABLE.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 12679000.00
RELIABLE.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 172000.00